Interestingly, androgen-mediated activation of AMPK has been shown to increase the growth of prostate cancer cells, associated with elevated intracellular ATP levels and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α)-mediated mitochondrial biogenesis [206]. Here, PPARGC1A is linked to prostate cancer.